PharmaIntel appoints Jacqui Batchelor
February 8, 2010Business Services, Sales and Marketing PharmaIntel, appointment, sales and marketing
PharmaIntel, the commercial excellence consultancy founded by Gary Killington in 2008, has appointed two new team members to manage the delivery …
Pfizer launches e-payment scheme for emerging markets
February 8, 2010Sales and Marketing Pfizer, discount, em, emerging markets
Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …
Roche expands Herceptin franchise
February 8, 2010Sales and Marketing Herceptin, Roche, gastric cancer, stomach cancer
Roche’s blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer. It is …
Pfizer to personalise brain tumour vaccine
February 8, 2010Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines
Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
Digital Pharma: UCB’s online epilepsy community
February 8, 2010Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information
UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …
Generics firm press for ‘clear and open’ market
February 8, 2010Sales and Marketing generics, industry
Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …
Carbogen Amcis opens large-scale high-potency API plant
February 8, 2010Manufacturing and Production Carbogen Amcis, Dishman, India
Carbogen Amcis, the Swiss subsidiary of Dishman Pharmaceuticals and Chemicals of India, has opened a new high-potency active pharmaceutical ingredient …
GSK appoints Philippe Fauchet president of GSK Japan
February 8, 2010Sales and Marketing GlaxoSmithKline, appointment, sales and marketing
GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …
Pharma manufacturing news in brief
February 8, 2010Manufacturing and Production, Medical Communications Angel Biotech, Catalent, Enzon, Genzyme, Gorbec Pharmaceuticals Services, Peakdale Molecular, Pfizer, Sigma-Tau, Synco Bio Partners
Our round-up of news in the pharmaceutical manufacturing arena covers developments at Genzyme, Enzon/Sigma-Tau, Catalent, Synco Bio Partners, Angel Biotech, …
UK swine flu cases fall
February 5, 2010Sales and Marketing h1n1, swine flu
The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …
GSK looks to rare diseases research
February 5, 2010Research and Development GlaxoSmithKline, Orphan
GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
Cohn & Wolfe appoints Mike Kan
February 5, 2010Medical Communications Cohn & Wolfe, appointment, medical communications
Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …
Recipharm charms Cobra shareholders into selling up
February 5, 2010Manufacturing and Production Cobra, Recipharm, Wasserburger
Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …
Barker praises OLS model
February 5, 2010Research and Development, Sales and Marketing ABPI, Blueprint, OLS
The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
GSK confirms job cuts but avoids specifics
February 5, 2010Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline
GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …
Miguel Forte joins TxCell
February 5, 2010Research and Development TxCell, appointment, research and development
French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …
Portfolio Harmony in five easy steps
February 5, 2010Sales and Marketing product portfolio
Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …
Zeftera problems weigh down Basilea
February 5, 2010Sales and Marketing 2009 financials, Basilea, Zeftera
Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …
GSK acquires respiratory candidate
February 4, 2010Research and Development Apeiron, GlaxoSmithKline, respiratory
GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …
Wyeth acquisition yet to shake Pfizer’s Lipitor dependence
February 4, 2010Sales and Marketing 2009 financials, Lipitor, Pfizer
Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
